Skip to main content

Advertisement

Log in

The Prevalence and Impact of Substance Use Disorder and Treatment on Maternal Obstetric Experiences and Birth Outcomes Among Singleton Deliveries in Massachusetts

  • Published:
Maternal and Child Health Journal Aims and scope Submit manuscript

Abstract

Objectives Despite widely-known negative effects of substance use disorders (SUD) on women, children, and society, knowledge about population-based prevalence and impact of SUD and SUD treatment during the perinatal period is limited. Methods Population-based data from 375,851 singleton deliveries in Massachusetts 2003–2007 were drawn from a maternal-infant longitudinally-linked statewide dataset of vital statistics, hospital discharges (including emergency department (ED) visits), and SUD treatment records. Maternal SUD and SUD treatment were identified from 1-year pre-conception through delivery. We determined (1) the prevalence of SUD and SUD treatment; (2) the association of SUD with women’s perinatal health service utilization, obstetric experiences, and birth outcomes; and (3) the association of SUD treatment with birth outcomes, using both bivariate and adjusted analyses. Results 5.5% of Massachusetts’s deliveries between 2003 and 2007 occurred in mothers with SUD, but only 66% of them received SUD treatment pre-delivery. Women with SUD were poorer, less educated and had more health problems; utilized less prenatal care but more antenatal ED visits and hospitalizations, and had worse obstetric and birth outcomes. In adjusted analyses, SUD was associated with higher risk of prematurity (AOR 1.35, 95% CI 1.28–1.41) and low birth weight (LBW) (AOR 1.73, 95% CI 1.64–1.82). Women receiving SUD treatment had lower odds of prematurity (AOR 0.61, 95% CI 0.55–0.68) and LBW (AOR 0.54, 95% CI 0.49–0.61). Conclusions for Practice SUD treatment may improve perinatal outcomes among pregnant women with SUD, but many who need treatment don’t receive it. Longitudinally-linked existing public health and programmatic records provide opportunities for states to monitor SUD identification and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bada, H. S., Das, A., Bauer, C. R., Shanrakan, S., Lester, B., et al. (2002). Gestational cocaine exposure and intrauterine growth: Maternal lifestyle study. Obstetrics and Gynecology, 100, 916–924.

    PubMed  Google Scholar 

  • Behnke, M., Smith, V. C., Committee on Substance Abuse, Committee on Fetus and Newborn. (2013). Prenatal substance abuse: Short- and long-term effects on the exposed fetus. Pediatrics, 131, e1009–1024.

    Article  PubMed  Google Scholar 

  • Bernstein, J., Belanoff, C., Cabral, H. J., Babakhanlou-Chase, H., Derrington, T., et al. (2015). Treatment outcomes for substance use disorder among women of reproductive age in Massachusetts. Drug and Alcohol Dependence, 147, 151–159.

    Article  PubMed  Google Scholar 

  • Bernstein, J., Bernstein, E., Belanoff, C., Cabral, H. J., Babakhanlou-Chase, H., et al. (2014). The association of injury with substance abuse disorder among women of reproductive age: An opportunity to address a major contributor to recurrent preventable ED visits? Academic Emergency Medicine, 21, 1459–1468.

    Article  PubMed  PubMed Central  Google Scholar 

  • Boucher, N., Bairam, A., & Beaulac-Baillargeon, L. (2008). A new look at the neonate's clinical presentation after in utero exposure to antidepressants in late pregnancy. Journal of Clinical Psychopharmacology, 28(3), 334–339.

  • Burns, L., & Mattick, R. P. (2007). Using population data to examine the prevalence and correlates of neonatal abstinence syndrome. Drug and Alcohol Review, 26(5), 487–492.

    Article  PubMed  Google Scholar 

  • CDC Number and age-adjusted rates of drug-poisoning deaths involving opioid analgesics and heroin: United States 2000–2014. Accessed 12/22/15 at http://www.cdc.gov/nchs/data/health_policy/AADR_drug_poisoning_involving_OA_Heroin_US_2000-2014.pdf.

  • Center for Behavioral Health Statistics and Quality. (2015). Behavioral health trends in the United States. Results from the 2014 National Survey on Drug Use and Health. (HHS Publication No. SMA 15-4927).

  • Conradt, E., Abar, B., Sheinkopf, S., Lester, B., et al. (2014). The role of prenatal substance exposure and early adversity on parasympathetic functioning from 3 to 6 years of age. Developmental Psychobiology, 56, 821–835.

    Article  PubMed  Google Scholar 

  • Crome, I. B., & Kumar, M. T. (2007). Epidemiology of drug and alcohol use in young women. Seminars in Fetal and Neonatal. Medicine, 12(2), 98–105.

    Google Scholar 

  • Derrington, T., Bernstein, J., Belanoff, C., Cabral, H. J., Babakhanlou-Chase, H., Diop, H., et al. (2015). Development of a grouping tool to identify women of child-bearing age with probable substance use disorders: the explicit-mention substance abuse need for treatment in women (EMSANT-W) algorithm. Maternal and Child Health Journal, 19(10), 2168–2178.

    Article  PubMed  PubMed Central  Google Scholar 

  • Escobar, G. J., Li, D. K., Armstrong, M. A., Gardner, M. N., Folck, B. F., et al. (2002). Neonatal sepsis workup in infants ≥2000 grams at birth: A population-based study. Pediatrics, 106, 256–263.

    Article  Google Scholar 

  • Fabris, C., Prandi, G., Perathoner, C., & Soldi, A. (1998). Neonatal drug addiction. Panminerva Medica, 40(3), 239–243.

    CAS  PubMed  Google Scholar 

  • Funkhouser, A. W., Butz, A. M., Feng, T. I., McCaul, M. E., & Rosenstein, B. J. (1993). Prenatal care and drug use in pregnant women. Drug and Alcohol Dependence, 33(1), 1–9.

    Article  CAS  PubMed  Google Scholar 

  • Harrison, P. A., & Sidebottom, A. C. (2008). Systematic prenatal screening for psychosocial risks. Journal of Health Care for the Poor and Underserved, 19(1), 258–276.

    Article  PubMed  Google Scholar 

  • Huestis, M. A., & Choo, R. E. (2002). Drug abuse’s smallest victims: In utero drug exposure. Forensic Science International, 128(1–2), 20–30.

    Article  PubMed  Google Scholar 

  • Kotelchuck, M. (1994). An evaluation of the kessner adequacy of prenatal care index and a proposed adequacy of prenatal care utilization index. American Journal of Public Health, 84(9), 1414–1420.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lester, B. M., & Lagasse, L. L. (2010). Children of addicted women. Journal of Addictive Disease, 29(2), 259–276. 

  • Lester, B. M., Tronick, E. Z., LaGasse, L., Seifer, R., Bauer, C. R., et al. (2002). The maternal lifestyle study: Effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics, 110(6), 1182–1192.

    Article  PubMed  Google Scholar 

  • McDonald, S. D., Vermeulen, M. J., & Ray, J. G. (2007). Risk of fetal death associated with maternal drug dependence and placental abruption: A population-based study. Journal of Obstetrics and Gynaecology of Canada, 29(7), 556–559.

    Article  Google Scholar 

  • Miller-Loncar, C., Lester, B. M., Seifer, R., Lagasse, L. L., Bauer, C. R., et al. (2005). Predictors of motor development in children prenatally exposed to cocaine. Neurotoxicology and Teratology, 27(2), 213–220.

    Article  CAS  PubMed  Google Scholar 

  • Ness, R. B., Grisso, J. A., Hirschinger, N., et al. (1999). Cocaine and tobacco use and the risk of spontaneous abortion. New England Journal of Medicine, 340(5), 333–339.

    Article  CAS  PubMed  Google Scholar 

  • Office of Applied Studies. (2007a). Substance abuse and mental health services administration. The NSDUH report: Substance use treatment among women of childbearing age. Rockville: National Clearinghouse for Alcohol and Drug Information.

    Google Scholar 

  • Office of Applied Studies. (2007b) Substance abuse and mental health services administration (SAMHSA). Results from the 2006 national survey on drug use and health: National findings. Rockville: National Clearinghouse for Alcohol and Drug Information.

    Google Scholar 

  • Office of Applied Studies. (2008) Substance abuse and mental health services administration (SAMHSA). Results from the 2007 national survey on drug use and health: National findings. Rockville: National Clearinghouse for Alcohol and Drug Information.

    Google Scholar 

  • Ornoy, A., Segal, J., Bar-Hamburger, R., Greenbaum C. (2001). Developmental outcome of school-age children born to mothers with heroin dependency: Importance of environmental factors. Developmental Medicine and Child Neurolology, 43(10), 668–675.

    Article  CAS  Google Scholar 

  • Pan, I. J., & Yi, H. Y. (2013). Prevalence of hospitalized births affected by alcohol and drug and parturient women diagnosed with substance abuse at live birth delivery: United States, 1999–2008. Maternal and Child Health Journal 17, 667–676.

  • Parlier, A. B., Fagan, B., Ramage, M., Galvin, S. (2014). Prenatal care, pregnancy outcomes, and postpartum birth control plans among pregnant women with opiate addictions. Southern Medical Journal, 107, 676–683.

    Article  PubMed  Google Scholar 

  • Roberts, S. C. M., & Pies, C. (2011). Complex calculations: How drug use during pregnancy becomes a barrier to prenatal care. Maternal and Child Health Journal, 15, 333–341.

    Article  PubMed  Google Scholar 

  • Shankaran, S., Das, A., Bauer, C. R., Bada, H. S., Lester, B., et al. (2004). Association between patterns of maternal substance use and infant birth weight, length, and head circumference. Pediatrics, 114(2), e226–e234.

    Article  PubMed  Google Scholar 

  • Tuthill, D. P. (2000). Tobacco and cocaine use were independent risk factors for spontaneous abortion in inner-city women. Evidence-based Obstetrics and Gynecology, 2(1), 14.

    Article  Google Scholar 

  • Wright, A., Walker, J. (2001). Drugs of abuse in pregnancy. Best Practice and Research in Clinical Obstetrics and Gynaecology, 15(6), 987–998.

    Article  CAS  Google Scholar 

Download references

Funding

Supported in part by NIH NIAAA R21AA018395, NIH NIDA R21DA027181, and supplemental funding from the Massachusetts Department of Public Health Bureau of Substance Abuse Services.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Milton Kotelchuck.

Appendix

Appendix

See Table 5.

Table 5 Association between substance use disorder treatments and preterm birth and low birthweight among singleton deliveries with identified SUD need, overall and by specific drug mentioned

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kotelchuck, M., Cheng, E.R., Belanoff, C. et al. The Prevalence and Impact of Substance Use Disorder and Treatment on Maternal Obstetric Experiences and Birth Outcomes Among Singleton Deliveries in Massachusetts. Matern Child Health J 21, 893–902 (2017). https://doi.org/10.1007/s10995-016-2190-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10995-016-2190-y

Keywords

Navigation